CCL3 and Miyoshi myopathy: We found that lower plasma levels of FGF‐2 (β = –1.10, p values = 7.8 × 10−7), fractalkine (β = –0.72, p values = 1.12 × 10−3), MCP‐3 (β = –0.91, p values = 1.36 × 10−4), MIP‐1α (β = –0.72, p values = 4.6 × 10−4), TGF‐α (β = –1.08, p values = 4.08 × 10−05), VEGF (β = –1.00, p values = 4.23 × 10−5) were associated with increased risk of MM (Supporting Information Table S5).